Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
RTNominal down97.550 -2.350 (-2.352%)
Research Report

04/02/2021 12:22

{I-bank focus}Daiwa lifts PA Good Doctor (01833) to HK$117

[ET Net News Agency, 4 February 2021] Daiwa Research lifted its target price for Ping
An Healthcare and Technology (PA Good Doctor) (01833) to HK$117 from HK$100 and reaffirmed
its "outperform" rating.
The research house said PA Good Doctor's analyst briefing provided more clarity on its
strategies for the next few years. In addition to its existing "2C" channels, through O2O
synergies from Ping An Insurance Group, Daiwa expects PA Good Doctor to capitalise on its
"2B" corporate customers channel and insurance channel.
Daiwa reiterated its view that the key competitive advantages of PA Good Doctor over its
competitors are its large user traffic, strong AI and rising monetisation in online
medical services, rather than health mall. Going forward, it expects revenue from online
medical services to significantly outperform other business segments.
Daiwa expects gross profit contribution from online medical services to reach 80% by
2023. It raised its 2021-22 revenue by 12-17% due to its strong momentum in monetisation
of its core online medical services business, led by membership products. (KL)

Remark: Real time quote last updated: 12/04/2021 12:29
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2021 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.